Clinical Trials at NYU Langone Health

As of July 2026, 244 paid clinical trials are recruiting at NYU Langone Health, located at 550 1ST AVE, NEW YORK, NY 10016, phone (212) 263-1481 in New York, New York. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

247 clinical trials at NYU Langone Health

·Clear filters·↓ Download CSV

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

for Primary Membranous Nephropathy

Sites in New York +18 more locations

Sponsor: Cerium Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05696613·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

for Hematological Malignancies

Drug: Talquetamab

Sites in New York, Rochester +8 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT04634552·Phase 2·Recruiting·Listed Nov 2020

Apply to this trial

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for Non-Small Cell Lung Cancer

Sites in New York +15 more locations

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All·Age: 18+

Code: NCT06917079·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for PDAC

Sites in New York +17 more locations

Sponsor: Tango Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

for Peripheral Nerve Injury Upper Limb

Sites in New York +23 more locations

Sponsor: Neuraptive Therapeutics Inc.

Sex: All·Age: 18 - 80

Code: NCT06616025·Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

for Advanced Cancer

Sites in New York +14 more locations

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05557045·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

for Pancreatic Cancer

Sites in New York, The Bronx +11 more locations

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18 - 120

Code: NCT06698458·Recruiting·Listed Nov 2024

Apply to this trial

QTX3034 in Patients With KRAS G12D Mutation

for Solid Tumors

Sites in New York, The Bronx +12 more locations

Sponsor: Quanta Therapeutics

Sex: All·Age: 18+

Code: NCT06227377·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for Non-Small Cell Lung Cancer (NSCLC)

Drug: daraxonrasib

Sites in New York +17 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT06128551·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Acellular Dermal Matrix Investigation in Breast Reconstruction

for Breast Reconstruction

Sites in New York +12 more locations

Sponsor: RTI Surgical

Sex: Female·Age: 22+·Accepts healthy volunteers

Code: NCT06456554·Recruiting·Listed Jun 2024

Apply to this trial

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

for Recurrent Pericarditis

Sites in New York +20 more locations

Sponsor: Cardiol Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06708299·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

for Non Small Cell Lung Cancer

Sites in New York +14 more locations

Sponsor: Tango Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06810544·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in New York, Manhasset +22 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06456463·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

for Recurrent or Metastatic Solid Tumors

Sites in New York, Westbury +14 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06330064·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for Advanced Solid Tumor

Sites in New York +20 more locations

Sponsor: Clasp Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06778863·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Sites in New York +15 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06747351·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for Locally Advanced Solid Tumor

Sites in New York +18 more locations

Sponsor: Nuvalent Inc.

Sex: All·Age: 12+

Code: NCT05118789·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for Solid Tumor, Adult

Sites in New York +12 more locations

Sponsor: GV20 Therapeutics

Sex: All·Age: 18+

Code: NCT05669430·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

for Solid Tumor, Adult

Sites in New York +9 more locations

Sponsor: A2 Biotherapeutics Inc.

Sex: All·Age: 18+

Code: NCT06682793·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

for Low-grade Glioma

Sites in New York +11 more locations

Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All·Age: 6 Months - 25

Code: NCT04775485·Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

Pilot/Pivotal Study of DBS+Rehab After Stroke

for Stroke

Sites in New York +8 more locations

Sponsor: Enspire DBS Therapy, Inc.

Sex: All·Age: 21+

Code: NCT05701280·Recruiting·Listed Jan 2023

Apply to this trial

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

for Glioblastoma Multiforme of Brain

Sites in New York +2 more locations

Sponsor: Tetragon Biosciences Ltd

Sex: All·Age: 18+

Code: NCT07464925·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

for Moderately to Severely Active Ulcerative Colitis

Drug: Afimkibart

Sites in New York +2 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 2 - 17

Code: NCT07158242·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

for Metastatic Castration-resistant Prostate Neoplasms

Drug: Pasritamig

Sites in New York, Brooklyn +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: Male·Age: 18+

Code: NCT05818683·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt

for Right-To-Left Shunt

Sites in New York +6 more locations

Sponsor: Agitated Solutions, Inc.

Sex: All·Age: 18+

Code: NCT06938347·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain

for Amputation

Sites in New York +4 more locations

Sponsor: AtriCure, Inc.

Sex: All·Age: 18+

Code: NCT06908538·Recruiting·Listed Apr 2025

Apply to this trial

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

for Neoplasms

Sites in New York +2 more locations

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All·Age: 18+

Code: NCT06311578·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for Endometrial Cancer

Sites in New York, Mineola +6 more locations

Sponsor: BioNTech SE

Sex: Female·Age: 18+

Code: NCT06340568·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)

for Ileal Pouch

Sites in New York +7 more locations

Sponsor: Exegi Pharma, LLC

Sex: All·Age: 18+

Code: NCT05938465·Phase 1, Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced or Metastatic Solid Tumors

Sites in New York +7 more locations

Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All·Age: 18+

Code: NCT06307795·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

for Thyroid Nodule

Sites in New York +2 more locations

Sponsor: Pulse Biosciences, Inc.

Sex: All·Age: 22 - 80

Code: NCT07287176·Recruiting·Listed Dec 2025

Apply to this trial

ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC

for Solid Tumors

Drug: Amivantamab

Sites in New York +1 more location

Sponsor: ORIC Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06816992·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

for Recurrent Glioblastoma

Sites in New York +2 more locations

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18 - 85

Code: NCT06910306·Recruiting·Listed Apr 2025

Apply to this trial

PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717

for Prion Disease

Sites in New York +2 more locations

Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06153966·Phase 1, Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

for VEXAS

Drug: Pacritinib

Sites in New York +8 more locations

Sponsor: Swedish Orphan Biovitrum

Sex: All·Age: 18+

Code: NCT06782373·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for Colorectal Cancer

Sites in New York +8 more locations

Sponsor: Criterium, Inc.

Sex: All·Age: 18+

Code: NCT06992258·Phase 2·Recruiting·Listed May 2025

Apply to this trial

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

for Acute Myelogenous Leukemia

Sites in New York +1 more location

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All·Age: 18+

Code: NCT06656494·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

The Prism Conformity Trial for Post-Traumatic Stress Disorder in Adolescents

for Post-Traumatic Stress Disorder in Adolescence

1 location in New York

Sponsor: GrayMatters Health Ltd.

Sex: All·Age: 12 - 21

Code: NCT06854328·Recruiting·Listed Mar 2025

Apply to this trial

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

for Chronic Limb-Threatening Ischemia

Sites in New York & Staten Island

Sponsor: R3 Vascular Inc.

Sex: All·Age: 18+

Code: NCT06071429·Recruiting·Listed Oct 2023

Apply to this trial

A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia

for Oculopharyngeal Muscular Dystrophy

1 location in New York

Sponsor: Benitec Biopharma, Inc.

Sex: All·Age: Up to 65

Code: NCT06185673·Phase 1, Phase 2·Recruiting·Listed Dec 2023

Apply to this trial